Quantum Biosystems
Quantum Biosystems develops quantum-based biosensing technologies for life science research and molecular detection. The company creates platforms that leverage quantum mechanical principles to detect and analyze biological molecules at unprecedented sensitivity levels. Founded in 2013, headquartered in Osaka, Japan, The company has raised $35.0M at the Series C stage, backed by investors including SBI Investment,…
Funding snapshot
About
Quantum Biosystems develops quantum-based biosensing technologies for life science research and molecular detection. The company creates platforms that leverage quantum mechanical principles to detect and analyze biological molecules at unprecedented sensitivity levels. Founded in 2013, headquartered in Osaka, Japan, The company has raised $35.0M at the Series C stage, backed by investors including SBI Investment, INCJ, Mitsubishi UFJ Capital, UTEC, Mizuho Financial Group. The company operates in the Life Sciences > Genomics, Life Sciences > Life Sciences Platforms and Tools, High Tech > Nanotechnology sector. with business models spanning Nanotechnology > Nanotools > Genomics > DNA Sequencing, Quantum Computing > Applications > Life Sciences. serving markets in Japan. Developing DNA sequencers based on quantum mechanics..
Business model
Nanotechnology > Nanotools > Genomics > DNA Sequencing,
Quantum Computing > Applications > Life Sciences,
Genomics > Enabling Technologies > Instrument Systems > Nucleic Acid Analysis > Sequencing,
Life Sciences Platforms and Tools > Instruments > Genomics > Nucleic Acid Sequencing
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.